Bandingkan Harga & Kinerja Morenzo Abadi Perkasa Tbk. (ENZO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Morenzo Abadi Perkasa Tbk. dan Organon Pharma Indonesia Tbk.: Morenzo Abadi Perkasa Tbk. diperdagangkan di Rp78 (kapitalisasi pasar 162,19 M, volume 24 jam 121,54 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Morenzo Abadi Perkasa Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| ENZO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 162,19 M | 104,4 M |
Volume | 121,54 jt | — |
Lot | 1,22 jt | — |
Perputaran | 9,5 M | — |
Harga Rata-rata | 78,21 | — |
Nilai Transaksi | 9,5 M | — |
Harga Ekuilibrium Indikatif | 78 | — |
Volume Ekuilibrium Indikatif | 28,2 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Morenzo Abadi Perkasa Tbk.
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Selengkapnya di halaman ENZO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
